5-43609170-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_182977.3(NNT):c.-26T>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.306 in 1,583,958 control chromosomes in the GnomAD database, including 79,343 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.24 ( 5432 hom., cov: 32)
Exomes 𝑓: 0.31 ( 73911 hom. )
Consequence
NNT
NM_182977.3 5_prime_UTR
NM_182977.3 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.312
Genes affected
NNT (HGNC:7863): (nicotinamide nucleotide transhydrogenase) This gene encodes an integral protein of the inner mitochondrial membrane. The enzyme couples hydride transfer between NAD(H) and NADP(+) to proton translocation across the inner mitochondrial membrane. Under most physiological conditions, the enzyme uses energy from the mitochondrial proton gradient to produce high concentrations of NADPH. The resulting NADPH is used for biosynthesis and in free radical detoxification. [provided by RefSeq, Sep 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 5-43609170-T-C is Benign according to our data. Variant chr5-43609170-T-C is described in ClinVar as [Benign]. Clinvar id is 1325907.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.329 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NNT | NM_182977.3 | c.-26T>C | 5_prime_UTR_variant | Exon 2 of 22 | ENST00000344920.9 | NP_892022.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.238 AC: 36113AN: 151920Hom.: 5434 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
36113
AN:
151920
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.263 AC: 63154AN: 240306 AF XY: 0.273 show subpopulations
GnomAD2 exomes
AF:
AC:
63154
AN:
240306
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.313 AC: 447802AN: 1431920Hom.: 73911 Cov.: 28 AF XY: 0.312 AC XY: 221368AN XY: 709486 show subpopulations
GnomAD4 exome
AF:
AC:
447802
AN:
1431920
Hom.:
Cov.:
28
AF XY:
AC XY:
221368
AN XY:
709486
Gnomad4 AFR exome
AF:
AC:
1780
AN:
32680
Gnomad4 AMR exome
AF:
AC:
7841
AN:
41808
Gnomad4 ASJ exome
AF:
AC:
9392
AN:
25252
Gnomad4 EAS exome
AF:
AC:
3758
AN:
39320
Gnomad4 SAS exome
AF:
AC:
19945
AN:
81306
Gnomad4 FIN exome
AF:
AC:
18159
AN:
52944
Gnomad4 NFE exome
AF:
AC:
367020
AN:
1093750
Gnomad4 Remaining exome
AF:
AC:
17985
AN:
59200
Heterozygous variant carriers
0
13203
26407
39610
52814
66017
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
11698
23396
35094
46792
58490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.237 AC: 36103AN: 152038Hom.: 5432 Cov.: 32 AF XY: 0.236 AC XY: 17517AN XY: 74334 show subpopulations
GnomAD4 genome
AF:
AC:
36103
AN:
152038
Hom.:
Cov.:
32
AF XY:
AC XY:
17517
AN XY:
74334
Gnomad4 AFR
AF:
AC:
0.0630698
AN:
0.0630698
Gnomad4 AMR
AF:
AC:
0.236177
AN:
0.236177
Gnomad4 ASJ
AF:
AC:
0.354551
AN:
0.354551
Gnomad4 EAS
AF:
AC:
0.0666667
AN:
0.0666667
Gnomad4 SAS
AF:
AC:
0.233002
AN:
0.233002
Gnomad4 FIN
AF:
AC:
0.343661
AN:
0.343661
Gnomad4 NFE
AF:
AC:
0.332446
AN:
0.332446
Gnomad4 OTH
AF:
AC:
0.272986
AN:
0.272986
Heterozygous variant carriers
0
1335
2670
4004
5339
6674
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
376
752
1128
1504
1880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
529
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Glucocorticoid deficiency 4 Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at